Cabot (CBT) Scheduled to Post Quarterly Earnings on Monday

Cabot (NYSE:CBTGet Free Report) is set to release its earnings data after the market closes on Monday, May 6th. Analysts expect Cabot to post earnings of $1.66 per share for the quarter. Cabot has set its FY24 guidance at $6.30-$6.80 EPS and its FY 2024 guidance at 6.300-6.800 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

Cabot (NYSE:CBTGet Free Report) last announced its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.07. The firm had revenue of $958.00 million for the quarter, compared to the consensus estimate of $927.28 million. Cabot had a net margin of 11.24% and a return on equity of 25.52%. On average, analysts expect Cabot to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Cabot Stock Performance

Shares of CBT stock opened at $94.10 on Friday. The firm has a 50 day moving average of $90.34 and a two-hundred day moving average of $81.17. The company has a quick ratio of 1.30, a current ratio of 2.04 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $5.22 billion, a PE ratio of 12.22, a P/E/G ratio of 0.97 and a beta of 1.27. Cabot has a 52 week low of $63.73 and a 52 week high of $98.34.

Analyst Ratings Changes

CBT has been the topic of several analyst reports. Mizuho initiated coverage on shares of Cabot in a report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 target price on the stock. UBS Group cut Cabot from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $90.00 to $87.00 in a research report on Monday, January 8th. Deutsche Bank Aktiengesellschaft lowered Cabot from a “buy” rating to a “hold” rating and boosted their target price for the company from $88.00 to $95.00 in a report on Thursday, April 18th. Finally, StockNews.com downgraded Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Cabot presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.17.

View Our Latest Report on CBT

Insider Buying and Selling

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares in the company, valued at $7,767,331.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.07% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.